Streetbeat News

Stock Prices

CCL

Barclays analyst Brandt Montour has maintained an Overweight rating on Carnival (NYSE:CCL) and increased the price target from $24 to $25.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:03 pm

NRXP

NRx Pharmaceuticals has announced a 1-for-10 reverse stock split in an effort to maintain its Nasdaq listing. This corporate action is a strategic move to comply with Nasdaq's minimum bid price requirement.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:03 pm

VNO

Analysts have mixed views on Vornado Realty (NYSE:VNO), with recent ratings ranging from indifferent to bearish. The average 12-month price target is $24.75, down from $26.50, indicating a 6.6% decrease. Vornado faces revenue challenges with a -1.13% decline over 3 months, but has strong net margin and ROE. Its debt-to-equity ratio is high at 2.08, suggesting financial leverage concerns.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 12:01 pm

WB

Recent analyst ratings for Weibo (NASDAQ:WB) show a mix of perspectives, with a shift towards a more cautious outlook over the last three months. The average 12-month price target has been lowered to $10.47, indicating a 20.98% decrease from the previous target. Analysts from Goldman Sachs, UBS, HSBC, and B of A Securities have adjusted their ratings and price targets, reflecting concerns over Weibo's market position, revenue trends, and debt management despite its strong profitability indicators.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 12:01 pm

PRGS

In the last three months, 4 analysts have updated their ratings on Progress Software (NASDAQ:PRGS), showing a shift towards a more bullish outlook. The average 12-month price target is now $65.25, slightly down by 0.12%. Analysts from DA Davidson, JP Morgan, Oppenheimer, and Wedbush have provided updates, with actions ranging from maintaining to raising price targets. Progress Software, a provider of cloud-based security solutions, has shown impressive revenue growth of 12.63% as of November 30, 2023, but lags behind industry peers. Its net margin and ROA outperform industry averages, while its ROE and market capitalization are below benchmarks.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 12:01 pm

CARA

Cara Therapeutics (NASDAQ:CARA) has been reviewed by 4 analysts in the last three months, showing a shift towards a more bullish stance. The average 12-month price target is now $6.25, down from $8.50, indicating a 26.47% decrease. The company, a biotech focused on novel therapeutics for pain and pruritus, faces challenges with a revenue decline of -7.88% and a net margin of -1076.46%, but has a low debt-to-equity ratio of 0.11.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 12:00 pm

RPHM

Reneo Pharmaceuticals (NASDAQ:RPHM) reported Q4 earnings with an EPS of $-0.7, missing estimates by -13.0% and showing no revenue change from the previous year. Despite missing EPS estimates last quarter, the share price increased by 1.0% the following day.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 12:00 pm

AAPL

Gene Munster of Deepwater Asset Management predicts Apple Inc.'s WWDC 2024 will introduce significant changes in operating system design with a focus on generative AI, marking the most substantial shift since the 1980s. This includes potential upgrades to core apps and Siri. However, Munster notes Apple is playing catch-up in the generative AI space, with competitors like Microsoft and Google already advancing. Apple's recent acquisition of DarwinAI and possible licensing of Google's Gemini AI for iOS 18 suggest a major push into AI.

Portfolio Pulse from Rounak Jain

March 28, 2024 | 11:58 am

RH

JP Morgan analyst Christopher Horvers has maintained an Overweight rating on RH (NYSE:RH) and increased the price target from $329 to $345.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:57 am

RUM

Rumble's stock price has decreased due to the company reporting lower than expected revenue for the fourth quarter.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:53 am